KFDA to designate tadalafil-containing preparations having possible abuse and misuse of medicine

The Korea Food and Drug Administration announced on August 19 that tadalafil-containing preparations for the treatment of erectile dysfunction will be additionally designated as the possible abuse and misuse of medicines, according to the proposed rules concerning the designation of possible abuse and misuse of medicines.

The KFDA noted that tadalafil preparations may be used as a male stimu...